GEN Exclusives

More »

GEN News Highlights

More »
Aug 6, 2007

MitoPharm Licenses New Extraction Method

  • MitoPharm signed an exclusive, worldwide licensing agreement with the Hong Kong University of Science and Technology for the use and commercialization of its patent-pending process for the extraction of (-) Schisandrin B and Schisandrin B.

    MitoPharm reports that it thus gains the first commercial-scale process for the extraction of Schisandrin B that delivers a high degree of purity and well-defined bacterial levels. The process incorporates hybrid chromatography, which is widely used in the fine chemical and pharmaceutical industries for the recovery of high-purity products.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Value-Pricing Cancer Drugs

Do you think all new cancer drugs awaiting approval should undergo value-pricing?

More »